(Total Views: 397)
Posted On: 01/04/2018 10:17:37 PM
Post# of 30066
Someone also posted Elto was worthless but it appears they were wrong. None of us know where each of those assets stand in the medical/bio community.
Did they get better with age like MANF, Elto and ESS or worthless as you say. One thing I know for sure is people still cant get easily tested for any of this so the market is still wide open.
Be interesting if AMBS createa a sub for dx, include MANF biomarker for 4-5 indication, spin it off and uplist.
Did they get better with age like MANF, Elto and ESS or worthless as you say. One thing I know for sure is people still cant get easily tested for any of this so the market is still wide open.
Be interesting if AMBS createa a sub for dx, include MANF biomarker for 4-5 indication, spin it off and uplist.
(5)
(0)
